FIBROGEN INC·4

Sep 10, 8:31 PM ET

Kouchakji Elias 4

4 · FIBROGEN INC · Filed Sep 10, 2019

Insider Transaction Report

Form 4
Period: 2019-09-06
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
  • Tax Payment

    Common Stock

    2019-09-06$41.68/sh5,541$230,949103,658 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION